Dec 5, 2018 by Daniel B. KlineCable Isn’t Dead YetAnd it’s probably not dying any time soon. But the cable space is definitely changing in some major ways.
Dec 4, 2018 by Matt Frankel, CFPAnother Data Breach, the Dark Side of Cryptocurrencies, and One Big Retirement MistakeReal risk accompanies all three.
Dec 4, 2018 by Evan Niu, CFAApple vs. Microsoft -- The Battle for World's Largest Market CapThe Apple-Microsoft rivalry is getting a gritty modern reboot as both companies battle for that $1 trillion market cap.
Dec 3, 2018 by Brian FeroldiHow to Tell if Solar Is Right for YouWant a 12% return on investment for greening up your house? Solar panels might be the way to go.
Nov 30, 2018 by Todd CampbellIs It Time to Buy These Beaten-Up Bargains in Healthcare?The stock market's November swoon has put these top healthcare stocks on sale.
Nov 28, 2018 by Asit Sharma, CPAYeti Hits the Market with a Cool New IPOYeti makes coolers, cups, dog bowls, and more. Now, investors can buy in -- but should they?
Nov 27, 2018 by Matt Frankel, CFPSmall-Cap Banks, Amazon Pay, and MoreHere are four small-cap banks that probably aren't on your radar yet, and here's what Amazon Pay could mean to PayPal and its other competitors.
Nov 27, 2018 by Dylan LewisInterview With Kyle PoundersCatching up on the Excaliburger food truck dynamo's unpredictable adventures since we saw him last.
Nov 20, 2018 by Matt Frankel, CFPHow to Invest in Real Estate (for Beginners)Here’s what investors need to know about adding real estate to their portfolio, as well as why Warren Buffett spent an eleven-figure sum on bank stocks last quarter.
Nov 13, 2018 by Matt Frankel, CFPCryptocurrencies, Square Earnings, and The Motley Fool’s New Personal-Finance BrandHere’s an interview with our resident cryptocurrency expert, as well as the latest from around the financial sector.
Nov 13, 2018 by Brian FeroldiInvesting in the Facebook of FreelancingThe largest online freelance marketplace in the world just went public. Are shares a buy?
Nov 8, 2018 by Todd CampbellWhy Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&AHere's what derailed the drug, and why Illumina is paying $1.2 billion to acquire Pacific Biosciences.
Nov 6, 2018 by Matt Frankel, CFPThis Week in the Financials Sector: Earnings, Wage Growth, IRA Changes, and MoreIt was yet another big week for earnings, and the IRS announced a big change for retirement savers.
Nov 2, 2018 by Asit Sharma, CPAAfter a Brutal October, What's Next for GrubHub Investors?The latest sell-off punished the company's stock with shares shedding over 30%, but there is more to this niche e-commerce story.
Oct 31, 2018 by Motley Fool StaffA Roundup of Last Week’s Financial-Sector EarningsHere are three financial companies that just reported earnings and what you need to know about each.
Oct 31, 2018 by Matt Frankel, CFPBig News From the Money 20/20 ConferenceThe Money 20/20 conference in Las Vegas always produces some big announcements, and this year was no exception.
Oct 26, 2018 by Matt DiLalloBakken Is the New BlackHow investors can capitalize on the next big thing in shale, without exposing themselves to all that volatile oil risk.
Oct 26, 2018 by Motley Fool StaffOur Top Stock Ideas in Silicon Valley’s Biggest Bet in HealthcareThe Fools reveal three stock ideas for investors interested in personalized medicine and precision oncology.
Oct 26, 2018 by Motley Fool StaffAre Liquid Biopsies a Holy Grail for Cancer Treatment?This could be a game changer for the medical community, saving hundreds of thousands of lives and hundreds of billions of dollars.
